Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Davis

Showing results (331-340 of 358) with videos related to

Pageof 36
Sort By:
Science (New York, N.Y.)|March 8, 2022
KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19Jing Li, Maxim Zaslavsky, Yapeng Su, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Organoid modeling of tumor-associated macrophages reveals phagocytosis checkpoint blockade-induced conversion to an immunosuppressive SPP1+ phenotypeMichitaka Nakano, Lyong Heo, Yu-Ping Yang, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesYapeng Su, Daniel Chen, Christopher Lausted, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Science (New York, N.Y.)|December 12, 2024
Confronting risks of mirror lifeKatarzyna P Adamala, Deepa Agashe, Yasmine Belkaid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|November 2, 2023
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Nature Communications|February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancerAlexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.
Pageof 36

Showing results (331-340 of 358) with videos related to

Sort By:
Pageof 36
Science (New York, N.Y.)|March 8, 2022
KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19Jing Li, Maxim Zaslavsky, Yapeng Su, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Organoid modeling of tumor-associated macrophages reveals phagocytosis checkpoint blockade-induced conversion to an immunosuppressive SPP1+ phenotypeMichitaka Nakano, Lyong Heo, Yu-Ping Yang, et al.
Biorxiv : the Preprint Server for Biology|August 9, 2020
Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesYapeng Su, Daniel Chen, Christopher Lausted, et al.
Cell|February 12, 2022
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationKatharina Röltgen, Sandra C A Nielsen, Oscar Silva, et al.
Science (New York, N.Y.)|December 12, 2024
Confronting risks of mirror lifeKatarzyna P Adamala, Deepa Agashe, Yasmine Belkaid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|November 2, 2023
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Nature Communications|February 1, 2020
Comprehensive T cell repertoire characterization of non-small cell lung cancerAlexandre Reuben, Jiexin Zhang, Shin-Heng Chiou, et al.
Pageof 36